The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Best BPC 157 Oral Supplements: ProHealth's Triple Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026 BPC 157: Miracle Healing Peptide or Hidden Danger? Why Are People Injecting Themselves with Peptides? The New Yorker When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions